Interview at Redeye about the partnership with Zentiva
Christer Ahlberg, CEO of Cinclus Pharma, was interviewed at Redeye about the partnership with Zentiva.
Read more
Check out the latest updates from Cinclus Pharma
Christer Ahlberg, CEO of Cinclus Pharma, was interviewed at Redeye about the partnership with Zentiva.
Read more
Cinclus Pharma establishes a strategic alliance and licensing agreement with Zentiva, a leading European pharmaceutical company, for the commercialization and manufacturing of linaprazan glurate in Europe.
Read more
Christer Ahlberg, CEO of Cinclus Pharma, gave a presentation today at the Nordea Equities Healthcare Seminar, where he spoke about the company's ongoing clinical development and strategic direction.
Read more